SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 10-KSB/A-2
[X] Annual report pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934 (fee required) For the fiscal year ended May 31,
1995
[ ] Transition report pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934 (no fee required) For the transition period from
_______ to ______.
Commission File Number 0-16206
OAK TREE MEDICAL SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 02-040167
(State or other jurisdiction (I.R.S. Employer Identification Number)
of incorporation or organization)
16504 STONEHAVEN ROAD, MIAMI LAKES, FLORIDA 33014
(Address of principal executive office and zip code)
Registrant's telephone number including area code: (305) 822-8889
Securities registered pursuant to Section 12 (b) of the Act: None
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $.01 Par Value
(Title of Class)
Indicate by check mark whether the Registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the Registrant was required to file
such reports), and (2) has been subject to such filing requirements
for the past 90 days. Yes: No: X
Indicate by check mark if disclosure of delinquent filers pursuant to
Item 405 of Regulation S-B is not contained herein, and will not be contained,
to the best of registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-KSB or any
amendment to this Form 10-KSB. [ ]
The issuer's revenues for its most recent fiscal year were $2,652,889.
Number of shares of Common Stock, $.01 par value, outstanding as of
September 1, 1995: 2,073,857
Market value of voting stock (605,075 shares) held by non-
affiliates as of September 1, 1995: $4,840,600
Documents incorporated by reference: None.
<PAGE>
PART II
Item 8. Changes in and Disagreements with Accountants on
Accounting and Financial Disclosure
(a) Puritz & Weintraub served as the independent auditors of the
Company from May 1993 until January 24, 1996 when they resigned the engagement
in consultation with the Company. Puritz & Weintraub's report on the Company's
financial statements for the period ended May 31, 1993 and 1994, did not contain
an adverse opinion or a disclaimer of opinion, and was not qualified as to
uncertainty, audit scope or accounting principles. The decision to change
auditors was approved by the Company's Board of Directors. There have been no
disagreements with Puritz & Weintraub on any matter of accounting principles or
practices, financial statement disclosure or auditing scope or procedure during
their engagement.
(b) Simon Krowitz Bolin & Associates, PA, has been engaged by the
Company as of January 24, 1996 as its principal independent auditors.
2
<PAGE>
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.
Dated: January 29, 1996 OAK TREE MEDICAL SYSTEMS, INC.
By: /s/ Irwin Bosh Stack
Irwin Bosh Stack
Chairman of the Board
3
<PAGE>
